The honest calculation therefore needs both a flat-price scenario and a warning that the personalized checkout may differ
[DOI] [PMC free article] [PubMed] [Google Scholar] 35.Costagliola C., Romano V., De Tollis M., Aceto F., dellOmo R., Romano M.R., Pedicino C., Semeraro F
The predominant side effects include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting 10-50% of patients depending on the specific product and dose, particularly during dose escalation) Injection site reactions : redness, itching, or discomfort at the subcutaneous injection site Hypoglycaemia : particularly when combined with insulin or sulphonylureas Decreased appetite : an intended therapeutic effect that contributes to weight loss However, some patients do report changes in urinary frequency or patterns
The simple answer is no, GLP-1s do not cause thyroid cancer in humans